B, N., P, R., Q, H., K, L., A, B., W, G., . . . BA, B. (2025). Hydroxychloroquine reduces metastatic tumor burden in pancreatic adenocarcinoma through myeloperoxidase inhibition. Journal of inflammation (London, England), 22(1), 33. https://doi.org/10.1186/s12950-025-00456-8
Chicago Style (17th ed.) CitationB, Niemann, Rao P, Hopen Q, Landreth K, Basnet A, Geldenhuys W, Liu TW, and Boone BA. "Hydroxychloroquine Reduces Metastatic Tumor Burden in Pancreatic Adenocarcinoma Through Myeloperoxidase Inhibition." Journal of Inflammation (London, England) 22, no. 1 (2025): 33. https://doi.org/10.1186/s12950-025-00456-8.
MLA (9th ed.) CitationB, Niemann, et al. "Hydroxychloroquine Reduces Metastatic Tumor Burden in Pancreatic Adenocarcinoma Through Myeloperoxidase Inhibition." Journal of Inflammation (London, England), vol. 22, no. 1, 2025, p. 33, https://doi.org/10.1186/s12950-025-00456-8.